Companies / Oligomerix
Oligomerix
Bronx, United States
Oligomerix is a clinical stage biotechnology company pioneering the development of disease-modifying, oral small molecule therapeutics targeting protein aggregation in Alzheimer’s disease and rare neurodegenerative diseases
Oligomerix, based in Bronx, United States, has 1 investor on file, among them Counterview Capital. Its site was last checked 10 Nov 2026: site answers.
Investors
1 investor on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital |
More from Counterview Capital
19 companies on its checked portfolioIts portfolio leans to AI & Machine Learning (32%), Fintech (14%), Enterprise Software (8%).
See Counterview Capital's full profile · Who invests alongside it
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Oligomerix and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Counterview Capital adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/oligomerix.com/investors
# also
GET /v1/companies/oligomerix.com
GET /v1/companies/oligomerix.com/news